- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/775 - Apolipopeptides
Détention brevets de la classe C07K 14/775
Brevets de cette classe: 592
Historique des publications depuis 10 ans
|
43
|
29
|
41
|
47
|
43
|
41
|
27
|
36
|
38
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19681 |
26 |
| CSL Limited | 254 |
17 |
| Cerenis Therapeutics Holding SA | 30 |
13 |
| F. Hoffmann-La Roche AG | 7889 |
10 |
| Cornell University | 3250 |
10 |
| Lawrence Livermore National Security, LLC | 1903 |
9 |
| ABIONYX Pharma SA | 37 |
9 |
| Children's Medical Center Corporation | 1830 |
8 |
| University of Cincinnati | 853 |
8 |
| The General Hospital Corporation | 4675 |
7 |
| Toray Industries, Inc. | 6840 |
7 |
| Cleveland HeartLab, Inc. | 21 |
7 |
| National Cancer Center | 402 |
7 |
| Centre National de La Recherche Scientifique | 10202 |
6 |
| Duke University | 3040 |
6 |
| Northwestern University | 3314 |
6 |
| Alnylam Pharmaceuticals, Inc. | 1141 |
6 |
| Indiana University Research and Technology Corporation | 790 |
6 |
| The Jackson Laboratory | 328 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
6 |
| Autres propriétaires | 412 |